Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Late syphilis presenting with extensive granulomatous cutaneous and pulmonary involvement.

IDCases·2026
Same author

Effects of short-course preoperative endocrine therapy on tumour morphology and immunohistochemical profile in oestrogen receptor-positive, HER2-negative breast cancer.

Histopathology·2026
Same author

Metabolic heterogeneity and niche rewiring in bone marrow plasma cells from patients with MGUS, solitary bone plasmacytoma and multiple myeloma.

Blood cancer journal·2026
Same author

Longitudinal multi-platform profiling reveals temporal dynamics of HER2, TROP2, PD-L1 and tumor-infiltrating lymphocytes in triple-negative breast cancer.

medRxiv : the preprint server for health sciences·2026
Same author

Publisher Correction: GLP-1R-GIPR-PPARα/γ/δ quintuple agonism corrects obesity and diabetes in mice.

Nature·2026
Same author

Spatial transcriptomics maps distinct signatures of human intermuscular adipose expansion in mice.

medRxiv : the preprint server for health sciences·2026
Same journal

Presenting features and outcomes to standard systemic therapies in patients with MTAP-deleted advanced non-small cell lung cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same journal

Clinical Validation of a Multiplex Urine Biomarker Assay for Surveillance of Recurrent Bladder Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same journal

Epigenetic Liquid Biopsy Enables Universal Mutation-Agnostic Molecular Surveillance for High-Risk Neuroblastoma.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same journal

Claudin 18.2 Targeting: A Pan-Cancer Perspective.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same journal

High-Sensitivity ctDNA Analysis Uncovers Relevant Signals Missed by NGS in Pancreatic Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same journal

Pediatric Brain Tumor Consortium phase 1 study of CD40 agonist sotigalimab in pediatric and young adult patients with recurrent CNS tumors and newly-diagnosed DIPG.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
See all related articles

Related Experiment Video

Updated: Sep 27, 2025

Spatial Profiling of Protein and RNA Expression in Tissue: An Approach to Fine-Tune Virtual Microdissection
09:19

Spatial Profiling of Protein and RNA Expression in Tissue: An Approach to Fine-Tune Virtual Microdissection

Published on: July 6, 2022

5.1K

Spatial Metabolomics Identifies Distinct Tumor-Specific Subtypes in Gastric Cancer Patients.

Jun Wang1, Thomas Kunzke1, Verena M Prade1

  • 1Research Unit Analytical Pathology, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, Germany.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|April 8, 2022
PubMed
Summary
This summary is machine-generated.

New gastric cancer subtypes identified through tissue metabolomics offer improved classification. The T1 subtype shows a better prognosis and benefits from trastuzumab therapy, aiding personalized treatment strategies.

More Related Videos

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
07:50

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

5.7K
Author Spotlight: Unlocking the Mysteries of Oral Potential Malignancies
05:42

Author Spotlight: Unlocking the Mysteries of Oral Potential Malignancies

Published on: August 11, 2023

1.2K

Related Experiment Videos

Last Updated: Sep 27, 2025

Spatial Profiling of Protein and RNA Expression in Tissue: An Approach to Fine-Tune Virtual Microdissection
09:19

Spatial Profiling of Protein and RNA Expression in Tissue: An Approach to Fine-Tune Virtual Microdissection

Published on: July 6, 2022

5.1K
Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
07:50

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

5.7K
Author Spotlight: Unlocking the Mysteries of Oral Potential Malignancies
05:42

Author Spotlight: Unlocking the Mysteries of Oral Potential Malignancies

Published on: August 11, 2023

1.2K

Area of Science:

  • Oncology
  • Metabolomics
  • Molecular Pathology

Background:

  • Current gastric cancer classification relies on genomic, molecular, and morphological data.
  • A classification system based on tissue metabolomics is currently lacking.
  • This study introduces a novel approach to gastric cancer subtyping.

Purpose of the Study:

  • To define metabolically distinct gastric cancer subtypes.
  • To identify clinicopathological and molecular characteristics of these subtypes.
  • To investigate treatment responses across identified subtypes.

Main Methods:

  • Spatial metabolomics using high mass resolution imaging mass spectrometry on 362 gastric cancer patients.
  • K-means clustering to define tumor and stroma-related subtypes based on tissue metabolites.
  • Correlation analysis with clinicopathological features, molecular markers, and response to trastuzumab in an independent cohort.

Main Results:

  • Identified three tumor-specific subtypes (T1, T2, T3) and three stroma-specific subtypes with distinct metabolic profiles.
  • Tumor subtype T1 (HER2+MIB+CD3+) correlated with favorable markers, elevated nucleotide levels, enhanced DNA metabolism, and better prognosis.
  • T1 subtype patients demonstrated significant benefit from trastuzumab therapy, validated in an independent cohort.

Conclusions:

  • Tissue-based spatial metabolomics provides a valuable addition to gastric cancer classification.
  • Metabolic differences between subtypes correlate with molecular features and treatment response.
  • This approach can aid in selecting targeted treatment strategies for gastric cancer patients.